State Policies Could Impede New Efforts to Increase Access to Medications for Opioid Use Disorder

JAMA Health Forum. 2023 Mar 3;4(3):e230071. doi: 10.1001/jamahealthforum.2023.0071.

Authors

Benjamin A Barsky¹, Ateev Mehrotra^{2

3

4}, Haiden A Huskamp²

Affiliations

¹ Interfaculty Initiative in Health Policy, Edmond & Lily Safra Center for Ethics, Harvard University, Cambridge, Massachusetts.
² Department of Health Care Policy, Harvard Medical School, Cambridge, Massachusetts.
³ Division of General Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
⁴ OptumLabs, Eden Prairie, Minnesota.

No abstract available

Plain language summary

This Viewpoint discusses state policies that could impede access to medications for opioid use disorder via telemedicine.

MeSH terms

Buprenorphine* / therapeutic use
Health Services Accessibility
Humans
Opioid-Related Disorders* / drug therapy
Opioid-Related Disorders* / epidemiology
Policy

Substances

Buprenorphine

Grants and funding